Alzamend Neuro, Inc. (ALZN) has 12 identified peers for comparison in the Healthcare sector. Peers include ABOS, ADAG, ADVM, ALEC, DAWN, HOOK and others.
ALZN has a market capitalization of $3.2M, compared to an average peer market cap of $338.66M. ALZN is notably smaller than its average peer.
